Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Invested Capital (2016 - 2025)

Surgery Partners' Invested Capital history spans 12 years, with the latest figure at $1.8 billion for Q4 2025.

  • For Q4 2025, Invested Capital fell 4.17% year-over-year to $1.8 billion; the TTM value through Dec 2025 reached $1.8 billion, down 4.17%, while the annual FY2025 figure was $1.8 billion, 4.17% down from the prior year.
  • Invested Capital for Q4 2025 was $1.8 billion at Surgery Partners, down from $1.8 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $4.9 billion in Q4 2021 and bottomed at $1.7 billion in Q1 2021.
  • The 5-year median for Invested Capital is $3.0 billion (2023), against an average of $2.8 billion.
  • The largest annual shift saw Invested Capital soared 291.69% in 2021 before it plummeted 42.9% in 2025.
  • A 5-year view of Invested Capital shows it stood at $4.9 billion in 2021, then crashed by 39.05% to $3.0 billion in 2022, then increased by 3.47% to $3.1 billion in 2023, then tumbled by 39.15% to $1.9 billion in 2024, then fell by 4.17% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Invested Capital are $1.8 billion (Q4 2025), $1.8 billion (Q3 2025), and $3.3 billion (Q2 2025).